Malignancies of the ear in irradiated patients of nasopharyngeal carcinoma

Wu Chia Lo, Lai Lei Ting, Jenq Yuh Ko, Pei Jen Lou, Tsung Lin Yang, Yih Leong Chang, Cheng Ping Wang

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

To report on the clinical profiles and treatment experiences of patients with second primary ear malignancy after treatment of nasopharyngeal carcinoma (NPC). Study Design: Retrospective case series. Methods: A retrospective review of the clinical outcomes and pathology of 11 irradiated NPC patients who subsequently had second primary malignancies of the ear at a single institution. Results: Ten tumors were squamous cell carcinoma and one tumor was chondrosarcoma occurring within the radiation field of previous treatment for NPC. The interval between previous radiotherapy and diagnosis of ear malignancy was 3 to 27 years with a median time of 17 years. Six tumors were located in the external auditory canal, two in the middle ear cavity, two in the periauricular region and one in the mastoid cavity. Four patients underwent surgery, and the other seven patients underwent surgery plus adjuvant radiotherapy. The 3-year disease-free and overall survival rates were 30.3% and 20%, respectively. Conclusions: Postirradiated malignancy of the ear is extremely rare, but is one of the causes of death for NPC long-term survivors despite curative-intended treatment with surgery plus adjuvant radiotherapy is instituted.

Original languageEnglish
Pages (from-to)2151-2155
Number of pages5
JournalLaryngoscope
Volume118
Issue number12
DOIs
Publication statusPublished - Dec 1 2008
Externally publishedYes

Fingerprint

Ear
Neoplasms
Adjuvant Radiotherapy
Chondrosarcoma
Ear Canal
Mastoid
Clinical Pathology
Second Primary Neoplasms
Middle Ear
Therapeutics
Disease-Free Survival
Survivors
Nasopharyngeal carcinoma
Cause of Death
Squamous Cell Carcinoma
Radiotherapy
Survival Rate
Retrospective Studies
Radiation

Keywords

  • Postirradiated malignancy
  • Radiotherapy
  • Squamous cell carcinoma
  • Temporal bone

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Lo, W. C., Ting, L. L., Ko, J. Y., Lou, P. J., Yang, T. L., Chang, Y. L., & Wang, C. P. (2008). Malignancies of the ear in irradiated patients of nasopharyngeal carcinoma. Laryngoscope, 118(12), 2151-2155. https://doi.org/10.1097/MLG.0b013e3181839b8c

Malignancies of the ear in irradiated patients of nasopharyngeal carcinoma. / Lo, Wu Chia; Ting, Lai Lei; Ko, Jenq Yuh; Lou, Pei Jen; Yang, Tsung Lin; Chang, Yih Leong; Wang, Cheng Ping.

In: Laryngoscope, Vol. 118, No. 12, 01.12.2008, p. 2151-2155.

Research output: Contribution to journalArticle

Lo, WC, Ting, LL, Ko, JY, Lou, PJ, Yang, TL, Chang, YL & Wang, CP 2008, 'Malignancies of the ear in irradiated patients of nasopharyngeal carcinoma', Laryngoscope, vol. 118, no. 12, pp. 2151-2155. https://doi.org/10.1097/MLG.0b013e3181839b8c
Lo, Wu Chia ; Ting, Lai Lei ; Ko, Jenq Yuh ; Lou, Pei Jen ; Yang, Tsung Lin ; Chang, Yih Leong ; Wang, Cheng Ping. / Malignancies of the ear in irradiated patients of nasopharyngeal carcinoma. In: Laryngoscope. 2008 ; Vol. 118, No. 12. pp. 2151-2155.
@article{53e0490e3ffb4350b76276291d04b6ac,
title = "Malignancies of the ear in irradiated patients of nasopharyngeal carcinoma",
abstract = "To report on the clinical profiles and treatment experiences of patients with second primary ear malignancy after treatment of nasopharyngeal carcinoma (NPC). Study Design: Retrospective case series. Methods: A retrospective review of the clinical outcomes and pathology of 11 irradiated NPC patients who subsequently had second primary malignancies of the ear at a single institution. Results: Ten tumors were squamous cell carcinoma and one tumor was chondrosarcoma occurring within the radiation field of previous treatment for NPC. The interval between previous radiotherapy and diagnosis of ear malignancy was 3 to 27 years with a median time of 17 years. Six tumors were located in the external auditory canal, two in the middle ear cavity, two in the periauricular region and one in the mastoid cavity. Four patients underwent surgery, and the other seven patients underwent surgery plus adjuvant radiotherapy. The 3-year disease-free and overall survival rates were 30.3{\%} and 20{\%}, respectively. Conclusions: Postirradiated malignancy of the ear is extremely rare, but is one of the causes of death for NPC long-term survivors despite curative-intended treatment with surgery plus adjuvant radiotherapy is instituted.",
keywords = "Postirradiated malignancy, Radiotherapy, Squamous cell carcinoma, Temporal bone",
author = "Lo, {Wu Chia} and Ting, {Lai Lei} and Ko, {Jenq Yuh} and Lou, {Pei Jen} and Yang, {Tsung Lin} and Chang, {Yih Leong} and Wang, {Cheng Ping}",
year = "2008",
month = "12",
day = "1",
doi = "10.1097/MLG.0b013e3181839b8c",
language = "English",
volume = "118",
pages = "2151--2155",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "John Wiley and Sons Inc.",
number = "12",

}

TY - JOUR

T1 - Malignancies of the ear in irradiated patients of nasopharyngeal carcinoma

AU - Lo, Wu Chia

AU - Ting, Lai Lei

AU - Ko, Jenq Yuh

AU - Lou, Pei Jen

AU - Yang, Tsung Lin

AU - Chang, Yih Leong

AU - Wang, Cheng Ping

PY - 2008/12/1

Y1 - 2008/12/1

N2 - To report on the clinical profiles and treatment experiences of patients with second primary ear malignancy after treatment of nasopharyngeal carcinoma (NPC). Study Design: Retrospective case series. Methods: A retrospective review of the clinical outcomes and pathology of 11 irradiated NPC patients who subsequently had second primary malignancies of the ear at a single institution. Results: Ten tumors were squamous cell carcinoma and one tumor was chondrosarcoma occurring within the radiation field of previous treatment for NPC. The interval between previous radiotherapy and diagnosis of ear malignancy was 3 to 27 years with a median time of 17 years. Six tumors were located in the external auditory canal, two in the middle ear cavity, two in the periauricular region and one in the mastoid cavity. Four patients underwent surgery, and the other seven patients underwent surgery plus adjuvant radiotherapy. The 3-year disease-free and overall survival rates were 30.3% and 20%, respectively. Conclusions: Postirradiated malignancy of the ear is extremely rare, but is one of the causes of death for NPC long-term survivors despite curative-intended treatment with surgery plus adjuvant radiotherapy is instituted.

AB - To report on the clinical profiles and treatment experiences of patients with second primary ear malignancy after treatment of nasopharyngeal carcinoma (NPC). Study Design: Retrospective case series. Methods: A retrospective review of the clinical outcomes and pathology of 11 irradiated NPC patients who subsequently had second primary malignancies of the ear at a single institution. Results: Ten tumors were squamous cell carcinoma and one tumor was chondrosarcoma occurring within the radiation field of previous treatment for NPC. The interval between previous radiotherapy and diagnosis of ear malignancy was 3 to 27 years with a median time of 17 years. Six tumors were located in the external auditory canal, two in the middle ear cavity, two in the periauricular region and one in the mastoid cavity. Four patients underwent surgery, and the other seven patients underwent surgery plus adjuvant radiotherapy. The 3-year disease-free and overall survival rates were 30.3% and 20%, respectively. Conclusions: Postirradiated malignancy of the ear is extremely rare, but is one of the causes of death for NPC long-term survivors despite curative-intended treatment with surgery plus adjuvant radiotherapy is instituted.

KW - Postirradiated malignancy

KW - Radiotherapy

KW - Squamous cell carcinoma

KW - Temporal bone

UR - http://www.scopus.com/inward/record.url?scp=58149355490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149355490&partnerID=8YFLogxK

U2 - 10.1097/MLG.0b013e3181839b8c

DO - 10.1097/MLG.0b013e3181839b8c

M3 - Article

VL - 118

SP - 2151

EP - 2155

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 12

ER -